Actively Recruiting
Dronabinol After Arthroscopic Surgery
Led by Northwestern University · Updated on 2025-04-29
30
Participants Needed
1
Research Sites
257 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the proposed study is to evaluate the efficacy of dronabinol for postoperative pain after arthroscopic surgery of the knee. The investigators hypothesize that dronabinol will relieve pain, reduce opioid consumption and will result in few negative side effects. If this pilot study shows promising results the investigators will expand the trial to include additional arthroscopic surgeries (hip, shoulder) and other types of orthopaedic surgery.
CONDITIONS
Official Title
Dronabinol After Arthroscopic Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Patient who will undergo arthroscopic surgery of the knee including meniscectomy
- Patient who will undergo arthroscopic surgery of the knee including synovectomy
- Patient who will undergo arthroscopic surgery of the knee including chondroplasty
- Patient who will undergo arthroscopic surgery of the knee including loose body removal
You will not qualify if you...
- Patients under age 18 years
- Patients who cannot provide consent
- Patients who are pregnant, breastfeeding, or trying to become pregnant during the study
- Patients with an allergy to any study drug
- Patients who are lactose-intolerant
- Patients undergoing revision surgery
- Patients undergoing open surgery
- Patients with comorbidities preventing surgery
- Patients with a history of mania, depression, or schizophrenia
- Patients taking anticholinergic agents
- Patients taking benzodiazepines
- Patients taking central nervous system depressants
- Patients taking droperidol
- Patients taking hydroxyzine
- Patients taking levomepromazine or methotrimeprazine
- Patients taking monoamine oxidase inhibitors
- Patients taking ritonavir
- Patients taking selective serotonin reuptake inhibitors
- Patients taking sympathomimetics
- Patients taking St. John's Wort
- Patients with current diagnosed alcohol or drug abuse
- Patients who cannot or will not follow medication restrictions
- Patients who do not agree to abstain from marijuana, cannabidiol (CBD), alcohol, or other drugs during treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States, 60611
Actively Recruiting
Research Team
M
Melissa J Shauver, MPH
CONTACT
A
Abbie P Bennett, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here